FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved Organon LLC's supplemental application for Singulair (montelukast), leading to updated labeling for the product. This action may modify approve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Exercise-induced Bronchoconstriction

Drugs mentioned

• SINGULAIR (montelukast)

Snippet

SUPPL AP for SINGULAIR (MONTELUKAST SODIUM)